Items where authors include "Sabatine, M.S."

Article

Patel, S.M., Bonaca, M.P., Morrow, D.A. et al. (7 more authors) (2023) Lipoprotein(a) and benefit of antiplatelet therapy. JACC: Advances, 2 (9). 100675. ISSN 2772-963X

Magnani, G., Ardissino, D., Im, K. et al. (15 more authors) (2021) Predictors, type, and impact of bleeding on the net clinical benefit of long‐term Ticagrelor in stable patients with prior myocardial infarction. Journal of the American Heart Association, 10 (4). e017008.

Gencer, B., Li, X.S., Gurmu, Y. et al. (10 more authors) (2020) Gut microbiota‐dependent trimethylamine N‐oxide and cardiovascular outcomes in patients with prior myocardial infarction: A nested case control study from the PEGASUS‐TIMI 54 trial. Journal of the American Heart Association, 9 (10). e015331. ISSN 2047-9980

Dellborg, M., Bonaca, M.P., Storey, R.F. orcid.org/0000-0002-6677-6229 et al. (20 more authors) (2019) Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54. European Heart Journal - Cardiovascular Pharmacotherapy, 5 (4). pp. 200-206. ISSN 2055-6837

Bonaca, M.P., Wiviott, S.D., Morrow, D.A. et al. (21 more authors) (2018) Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54. Journal of the American Heart Association , 7 (22). e009260. ISSN 2047-9980

Fonarow, G.C., Keech, A.C., Pedersen, T.R. et al. (8 more authors) (2017) Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease. JAMA Cardiology, 2 (10). pp. 1069-1078. ISSN 2380-6583

Storey, R.F. orcid.org/0000-0002-6677-6229, Angiolillo, D.J., Bonaca, M.P. et al. (12 more authors) (2016) Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial. Journal of the American College of Cardiology, 67 (10). pp. 1145-1154. ISSN 0735-1097